Skip to main content

Table 2 Correlations between clinical findings and hepcidin mRNA expression levels in liver of patients with various liver conditions (n = 132)

From: Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C

Characteristic

Hepcidin mRNA level

Statistics

n

Mean ± SD

Median

r

P

Age, y

   

0.003

0.9764

Sex

    

0.0012a

Male

73

10,900 ± 13,100

6590

  

Female

59

5820 ± 10,700

2600

  

Virus infection

     

Male

     

HCV+

33

9120 ± 7660

6650

  

HBV+

23

11,800 ± 16,100

2600

  

HCV−HBV−

    

0.0611b

Non-iron overload

9

7750 ± 5320

6590

  

Iron overload

8

19,600 ± 23,000

15,800

  

Female

     

HCV+

23

5890 ± 7900

3690

  

HBV+

11

3000 ± 2190

2360

  

HCV−HBV−

    

0.0724b

Non-iron overload

15

1300 ± 1030

814.5

  

Iron overload

10

15,500 ± 20,800

6485

  

Total

     

HCV+

56

7790 ± 7850

5730

  

HBV+

34

8950 ± 13,900

3290

  

HCV−HBV−

    

0.7733b

Non-iron overload

24

3720 ± 4550

1650

  

Iron overload

18

17,300 ± 21,200

6770

  

ALT, IU/L

   

0.281

0.0013

AST, IU/L

   

0.249

0.0043

Serum albumin, g/dL

   

−0.036

0.7844

Bilirubin, mg/dL

   

0.239

0.0065

Hyaluronic acid, ng/mL

   

0.145

0.0968

RBC, ×104/mm3

   

0.171

0.0510

Hemoglobin, g/L

   

0.235

0.0073

Hematocrit, %

   

0.160

0.0675

Platelets, × 104/mm3

   

−0.174

0.0465

Serum iron, µg/dL

   

0.283

0.0012

Transferrin saturation, %

   

0.360

<0.0001

Serum ferritin, ng/mL

   

0.832

<0.0001

Liver histology

     

Inflammatory activity, 0/1/2/3c

   

0.073

0.4011

Fibrosis staging, 0/1/2/3/4d

   

0.031

0.7209

TISe

   

0.457

<0.0001

  1. ALT, alanine aminotransferase; AST, apsartate aminotransferase; RBC, red blood cell count. Statistics are Spearman rank correlation test unless otherwise noted. aWilcoxon rank-sum test. bKruskal-Wallis test. cIntensity of necroinflammatory lesions: 0, no histological activity; 1, mild activity; 2, moderate activity; 3, severe activity. d0, no fibrosis; 1, portal fibrosis without septa; 2, portal fibrosis with few septa; 3, numerous septa without cirrhosis; 4, cirrhosis. eTotal iron score proposed by Deugnier et al. (23).